[go: up one dir, main page]

AU2001234837A1 - Azapeptides useful in the treatment of hepatitis c - Google Patents

Azapeptides useful in the treatment of hepatitis c

Info

Publication number
AU2001234837A1
AU2001234837A1 AU2001234837A AU3483701A AU2001234837A1 AU 2001234837 A1 AU2001234837 A1 AU 2001234837A1 AU 2001234837 A AU2001234837 A AU 2001234837A AU 3483701 A AU3483701 A AU 3483701A AU 2001234837 A1 AU2001234837 A1 AU 2001234837A1
Authority
AU
Australia
Prior art keywords
azapeptides
hepatitis
useful
treatment
azapeptides useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001234837A
Inventor
Rumin Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU2001234837A1 publication Critical patent/AU2001234837A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001234837A 2000-02-08 2001-02-06 Azapeptides useful in the treatment of hepatitis c Abandoned AU2001234837A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18101700P 2000-02-08 2000-02-08
US60181017 2000-02-08
PCT/US2001/003768 WO2001058929A1 (en) 2000-02-08 2001-02-06 Azapeptides useful in the treatment of hepatitis c

Publications (1)

Publication Number Publication Date
AU2001234837A1 true AU2001234837A1 (en) 2001-08-20

Family

ID=22662539

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001234837A Abandoned AU2001234837A1 (en) 2000-02-08 2001-02-06 Azapeptides useful in the treatment of hepatitis c

Country Status (3)

Country Link
US (1) US6624290B2 (en)
AU (1) AU2001234837A1 (en)
WO (1) WO2001058929A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119072B2 (en) 2002-01-30 2006-10-10 Boehringer Ingelheim (Canada) Ltd. Macrocyclic peptides active against the hepatitis C virus
US6642204B2 (en) 2002-02-01 2003-11-04 Boehringer Ingelheim International Gmbh Hepatitis C inhibitor tri-peptides
US7091184B2 (en) 2002-02-01 2006-08-15 Boehringer Ingelheim International Gmbh Hepatitis C inhibitor tri-peptides
US20050075279A1 (en) 2002-10-25 2005-04-07 Boehringer Ingelheim International Gmbh Macrocyclic peptides active against the hepatitis C virus
WO2004103996A1 (en) 2003-05-21 2004-12-02 Boehringer Ingelheim International Gmbh Hepatitis c inhibitor compounds
MY148123A (en) 2003-09-05 2013-02-28 Vertex Pharma Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
MXPA06003141A (en) 2003-09-22 2006-06-05 Boehringer Ingelheim Int Macrocyclic peptides active against the hepatitis c virus.
EP1730167B1 (en) 2004-01-21 2011-01-12 Boehringer Ingelheim International GmbH Macrocyclic peptides active against the hepatitis c virus
ATE428714T1 (en) 2004-02-24 2009-05-15 Japan Tobacco Inc CONDENSED HETEROTETRACYCLIC COMPOUNDS AND THEIR USE AS HCV POLYMERASE INHIBITORS
US20070049593A1 (en) 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
UY29016A1 (en) 2004-07-20 2006-02-24 Boehringer Ingelheim Int ANALOGS OF INHIBITING DIPEPTIDES OF HEPATITIS C
EP1771454B1 (en) 2004-07-20 2011-06-15 Boehringer Ingelheim International GmbH Hepatitis c inhibitor peptide analogs
US7597884B2 (en) 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
US7659263B2 (en) 2004-11-12 2010-02-09 Japan Tobacco Inc. Thienopyrrole compound and use thereof as HCV polymerase inhibitor
AR055395A1 (en) 2005-08-26 2007-08-22 Vertex Pharma INHIBITING COMPOUNDS OF THE ACTIVITY OF SERINA PROTEASA NS3-NS4A OF HEPATITIS C VIRUS
US7964624B1 (en) 2005-08-26 2011-06-21 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases
US8017612B2 (en) 2006-04-18 2011-09-13 Japan Tobacco Inc. Piperazine compound and use thereof as a HCV polymerase inhibitor
EP1886685A1 (en) 2006-08-11 2008-02-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibition
WO2008118332A2 (en) * 2007-03-23 2008-10-02 Schering Corporation Hydrazido-peptides as inhibitors of hcv ns3-protease
WO2010039801A2 (en) 2008-10-02 2010-04-08 The J. David Gladstone Institutes Methods of treating hepatitis c virus infection
CN102448458B (en) 2009-03-18 2015-07-22 小利兰·斯坦福大学理事会 Methods and compositions for treating viral infections of the Flaviviridae family
WO2012107589A1 (en) 2011-02-11 2012-08-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment and prevention of hcv infections
US9364484B2 (en) 2011-12-06 2016-06-14 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for treating viral diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2684674B1 (en) 1991-12-10 1994-01-28 Thevac Sarl AZAPEPTIDES AND THEIR PREPARATION PROCESS.
ATE197157T1 (en) * 1994-03-17 2000-11-15 Fujirebio Kk AZAPEPTIDE DERIVATIVES

Also Published As

Publication number Publication date
WO2001058929A1 (en) 2001-08-16
US6624290B2 (en) 2003-09-23
US20020103135A1 (en) 2002-08-01

Similar Documents

Publication Publication Date Title
AU2001234837A1 (en) Azapeptides useful in the treatment of hepatitis c
AU2002223827A1 (en) Well treatment
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001213236A1 (en) Mini-cyclone biocollector and concentrator
AU2001280599A1 (en) Compounds and methods
AU2001253418A1 (en) Compounds and methods
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
AU4289100A (en) Dihydropyrimidines and their use in the treatment of hepatitis
AU5618501A (en) Dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis
AU2002211717A1 (en) Stresscopins and their uses
AU2002231206A1 (en) Treatment of depression
AU2002243363A1 (en) Use of aziridino-compounds in the treatment of immune dysfunctions
AU2001243394A1 (en) Compounds and methods
AU2001260774A1 (en) Bio-support and preparing method of the same
AU2001260834A1 (en) The treatment of herpes
AU2001261005A1 (en) Immune mediators and related methods
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2002213429A1 (en) Antiviral methods and compounds
AUPQ872300A0 (en) Compounds and methods
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2001236929A1 (en) Surface treatment
AU2001278951A1 (en) Compounds and methods
AU2000231564A1 (en) Phosphororganic compounds and the use thereof
AU2002222557A1 (en) Interferon therapeutic effect-potentiating agents